Key concerns highlighted inthe report included inadequate enforcement against copyright piracy and trademark counterfeiting,inadequate protection against unfair commercial use of undisclosed test and other data generated to obtain marketing approval for pharmaceutical products, the need to enact legislation to ratify the 1991 Act of the International Convention for the Protection of New Varieties